竞争性抑制 uracil DNA glycosylase 由一个修饰的核酸,其三酸盐是DNA聚合酶的基质
Haidong Huang1, James T Stivers, Marc M Greenberg
1Department of Chemistry, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA.
Journal of the American Chemical Society
|January 29, 2009
概括
一种新的DNA修复抑制剂,1'-cyano-2'-deoxyuridine (CNdU),可以通过聚合酶被纳入DNA中. 这允许通过准基切除修复来扩大对病毒和癌细胞的治疗效果.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 基切除修复 (BER) 酶是抗病毒和抗癌疗法的关键点.
- 核酸类似物可以抑制BER糖酶酶,但通常不会被DNA聚合酶接受,从而限制了它们的治疗潜力.
- 乌拉DNA糖酶 (UDG) 是BER通路中的一个关键酶.
研究的目的:
- 鉴定和描述可以通过细胞聚合酶纳入DNA的 uracil DNA glycosylase (UDG) 新型抑制剂.
- 探索1 - - 2 - 脱氧氨酸 (CNdU) 作为针对DNA修复的治疗剂的潜力.
- 调查CNdU的作用机制和强化抑制作用的可能性.
主要方法:
- 合成和表征1 - - 2 - 脱氧氨 (CNdU).
- 酶分析以确定CNdU对 uracil DNA glycosylase (UDG) 的抑制活性.
- 使用大肠杆菌DNA聚合酶I的Klenow片段 (exo(-)) 进行DNA聚合酶测定,以评估CNdU三酸盐在DNA中的结合.
主要成果:
- CNdU 是 uracil DNA glycosylase (UDG) 的一个纳米分子竞争性抑制剂.
- 相应的CNdU三酸盐是DNA聚合酶I的Klenow片段 (exo(-)) 的基质.
- 这代表了第一个通过模型复制聚合酶纳入DNA的UDG抑制剂.
结论:
- CNdU和相关类型是一种针对DNA修复的新型潜在治疗药物.
- 细胞聚合酶可以将这些抑制剂纳入DNA,从而可能放大它们的抑制作用.
- 这种方法通过利用细胞DNA复制机制,为开发抗病毒和抗癌药物提供了一种新的战略.
相关概念视频
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:43Proofreading
Synthesis of new DNA molecules starts when DNA polymerase links nucleotides together in a sequence that is complementary to the template DNA strand. DNA polymerase has a higher affinity for the correct base to ensure fidelity in DNA replication. The DNA polymerase furthermore proofreads during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.Errors during Replication Are Corrected by the DNA Polymerase EnzymeGenomic DNA is synthesized in...
01:31Proofreading
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Errors During Replication are Corrected by the DNA Polymerase Enzyme
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
02:27DNA Base Pairing
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,